Clexane and Cardiopulmonary failure - a phase IV clinical study of FDA data

Summary:

Cardiopulmonary failure is reported as a side effect among people who take Clexane (enoxaparin sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Cardiopulmonary failure when taking Clexane. It is created by eHealthMe based on reports of 14,633 people who have side effects when taking Clexane from the FDA, and is updated regularly.

What is Clexane?

Clexane has active ingredients of enoxaparin sodium. eHealthMe is studying from 14,679 Clexane users. Check the latest studies of Clexane.

What is Cardiopulmonary failure?

Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract) is found to be associated with 454 drugs and 644 conditions by eHealthMe. Check the latest studies of Cardiopulmonary failure.

On Jul, 05, 2026

14,633 people reported to have side effects when taking Clexane.
Among them, 20 people (0.14%) have Cardiopulmonary failure.

Could Clexane cause Cardiopulmonary failure?

Among these 20 people:

How long have people been on Clexane when they have Cardiopulmonary failure? *

What is the gender of people who have Cardiopulmonary failure when taking Clexane? *

female: 36.84 %
male: 63.16 %

What is the age of people who have Cardiopulmonary failure when taking Clexane? *

What are other drugs people take besides Clexane? *

What are other side effects people have besides Cardiopulmonary failure? *

Pneumonia: 8 people, 40.00%
Dyspnea (difficult or laboured breathing): 8 people, 40.00%
C-Reactive Protein Increased: 6 people, 30.00%
Fever: 6 people, 30.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 30.00%
Fluid Intake Reduced: 5 people, 25.00%
Laboratory Test Abnormal: 5 people, 25.00%
Swallowing Difficulty: 5 people, 25.00%
Sinus Bradycardia (an unusually slow heartbeat due to heart disease): 5 people, 25.00%
Loss Of Consciousness: 5 people, 25.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 5 people, 25.00%
Pain: 3 people, 15.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 10.00%
Nausea (feeling of having an urge to vomit): 2 people, 10.00%
Sleep Disorder: 2 people, 10.00%
Urinary Tract Infection: 1 person, 5.00%
Diabetes: 1 person, 5.00%
Abscess (pus): 1 person, 5.00%
Anaemia (lack of blood): 1 person, 5.00%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Clexane and have Cardiopulmonary failure?

- Check whether Cardiopulmonary failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clexane:

Clexane (14,679 reports)

Browse all side effects of Clexane:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiopulmonary failure:

Cardiopulmonary failure (454 drugs)

Browse all the conditions that are associated with Cardiopulmonary failure:

Cardiopulmonary failure (644 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium (the active ingredients of Clexane) and Clexane (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.